Medical Union Pharmaceuticals Company announced that it will issue approximately 1,824,878 common shares at an issue price of EGP 41 per share for gross proceeds of EGP 74,820,000 on December 27, 2020. The transaction will involve participation from existing investor, Egyptian International Pharmaceutical Industries Company (CASE:PHAR) and other existing shareholders for up to 37.303% of the total shares. The shares have a nominal value of EGP 10 and an issuance premium of EGP 31.